Literature DB >> 8772642

Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.

M Franceschi1, Z Kusić, D Franceschi, L Lukinac, S Roncević.   

Abstract

UNLABELLED: The long-term prognosis of patients with differentiated thyroid carcinoma depends on the early diagnosis and treatment of metastases and local recurrences. We evaluated serum thyroglobulin measurements, neck ultrasonography with ultrasound-guided biopsy and 131I whole-body scintigraphy in the follow-up of 359 patients after surgical thyroidectomy and radioiodine ablation of the thyroid remnant.
METHODS: Serum thyroglobulin levels were determined and considered abnormal when the values were > 5 ng/ml. Ultrasonography over the entire neck region and fine-needle aspiration biopsy of the mass or enlarged lymph nodes were carried out using 5- and 7.5-MHz transducers and 23-gauge needles. Whole-body scintigraphy was performed after administration of 185 MBq (5 mCi)131I.
RESULTS: Increased levels of thyroglobulin (ranging from 12 to > 600 ng/ml) were measured in 40 of 55 (73%) patients with metastases or local recurrences. Ultrasonography revealed occult neck masses that were not detected by other methods. Neck ultrasonography and ultrasound-guided biopsy were positive for malignancy in 23 patients. Thyroglobulin levels were undetectable in 12 (52%) of these patients and 131I whole-body scintigraphy was negative in 19 (83%) of them.
CONCLUSION: The combined use of three diagnostic modalities (measurement of serum thyroglobulin, neck ultrasonography with ultrasound-guided biopsy for detecting recurrences of carcinoma in the neck region and 131I whole-body scintigraphy) appears to give the best results in the follows-up patients with differentiated thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772642

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

Review 1.  Papillary thyroid cancer: medical management and follow-up.

Authors:  Richard T Kloos
Journal:  Curr Treat Options Oncol       Date:  2005-07

2.  Helix pomatia agglutinin binding glycoproteins in thyroid tumors.

Authors:  Rajeev Parameswaran; Gregory Sadler; Susan Brooks
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

3.  Value of post-therapeutic ¹³¹I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma.

Authors:  Chen-Tian Shen; Wei-Jun Wei; Zhong-Ling Qiu; Hong-Jun Song; Quan-Yong Luo
Journal:  Endocrine       Date:  2015-06-21       Impact factor: 3.633

Review 4.  Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.

Authors:  Yan-Li Xue; Zhong-Ling Qiu; Hong-Jun Song; Quan-Yong Luo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-15       Impact factor: 9.236

5.  Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.

Authors:  A S Alzahrani; H Raef; A Sultan; S Al Sobhi; S Ingemansson; M Ahmed; A Al Mahfouz
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

6.  Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.

Authors:  Naifa Lamki Busaidy; Maria E Cabanillas
Journal:  J Thyroid Res       Date:  2012-02-28

7.  A rare case report of very low thyroglobulin and a negative whole-body scan in a patient with a solid variant of papillary thyroid carcinoma with distant metastases.

Authors:  Wei Li; Danyang Sun; Hui Ming; Guizhi Zhang; Jian Tan
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 8.  Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer.

Authors:  Zhuan-Zhuan Mu; Xin Zhang; Yan-Song Lin
Journal:  Chonnam Med J       Date:  2019-09-24

9.  Thyroglobulin Measurement in Needle Aspiration for Detection of Recurrences and Neck Metastases in Patients with Differentiated Thyroid Carcinoma: Significance of Anti-Tg Antibodies.

Authors:  Ivan Blažeković; Matija Romić; Marija Bosak Butković; Ines Šiško Markoš; Vedrana Gladić Nenadić; Valentina Vidranski; Petra Petranović Ovčariček; Dražena Krilić; Tea Varjačić; Josip Staničić; Roko Granić; Marija Punda; Ivan Mihaljević; Tomislav Jukić; Maja Franceschi
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

10.  Current role of radionuclide imaging in differentiated thyroid cancer.

Authors:  K T Wong; Frankie P T Choi; Yolanda Y P Lee; Anil T Ahuja
Journal:  Cancer Imaging       Date:  2008-09-10       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.